The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is a clinical research site located in Torrance, California, United States 90502.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has participated in 13 clinical trials with 6 currently active.
Therapeutic areas: Pulmonary Embolism, Myocardial Infarction, HIV-1-infection.
Sponsors: Endovascular Engineering, Boehringer Ingelheim, Gilead Sciences.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has 13 clinical trials on record, with 6 currently active. Their work covers Pulmonary Embolism, Myocardial Infarction, HIV-1-infection.
Yes — The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.